Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer dynein arm docking complex subunit 2 (ODAD2) is a cytoplasmic protein that forms part of the outer dynein arm docking complex (ODA-DC), which is essential for the proper attachment and spatial arrangement of outer dynein arms on the axonemal doublet microtubules of cilia and flagella[2][3][7]. ODAD2 contains multiple armadillo repeat motifs and one HEAT repeat, indicating a role in protein–protein interactions and complex assembly[2]. It localizes specifically to ciliary axonemes and the base of respiratory cilia[2]. Functionally, ODAD2 helps mediate the binding and periodic arrangement of the dynein arms, which generate the force required for ciliary and flagellar motility. Loss-of-function mutations in ODAD2 cause defects in ciliary beating, contributing to conditions such as primary ciliary dyskinesia, which is characterized by chronic respiratory disease and defects in left-right body asymmetry due to impaired ciliary motility[2][8]. There are no known drugs directly targeting ODAD2, nor is it considered a therapeutic target, but its mutation status is relevant as a biomarker in the clinical genetics of ciliary disorders[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer dynein arm docking complex subunit 2 (ODAD2).